Global Prevalence of Alloimmunization in Adults with Sickle Cell Disease Receiving Red Blood Cell Transfusions: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 15.05.2026 · 15 (10) · 3828
DOI: 10.3390/jcm15103828 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.05.2026. Verfasst von Mortadah Alsalman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, King Faisal University, Al Ahsa 31982, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research at King Faisal University in Saudi Arabia gave this study mon…, Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research at King Faisal University.
Abstract (Originalsprache)
Background/Objectives: Blood transfusion is a crucial component in the treatment of individuals with sickle cell disease [SCD]; nonetheless, multiple transfusions can lead to considerable complications, notably alloimmunization. However, the prevalence of alloimmunization and its predictors remain incompletely explained. This review aimed to determine its global prevalence and identify associated risk factors.
Method
Our protocol was registered in PROSPERO [ID: CRD420251167042] in accordance with the PRISMA 2020 criteria. A thorough literature search was conducted across PubMed, Embase, Web of Science, Scopus, and the Cochrane Library to identify studies reporting the prevalence of alloimmunization in adults with confirmed sickle cell disease who have received blood transfusions. This search included all publications up to 16 April 2026. Two reviewers independently screened and extracted data, and the Newcastle–Ottawa Scale was used to evaluate the study’s quality. After the Freeman–Tukey transformation, a random-effects model was used to estimate the pooled prevalence. We examined disparities among groups and geographies, study designs, and matching procedures to determine their differences. We additionally employed meta-regression to identify potential predictors.
Results
Nine studies [n = 1711; 1978–2026] met the inclusion criteria. The overall rate of alloimmunization was 28.9% [95% CI 22.4–35.4; I2 = 88.5%]. The most prevalent antibodies were those of the Rh and Kell systems, with anti-E antibodies being the most frequent, followed by anti-C and anti-K antibodies. A higher number of transfusions and the HbSβ0 genotype were both persistent risk factors, while older age at first transfusion appeared protective. Extended antigen matching dramatically reduced prevalence, though approximately 9% of individuals remained affected.
Conclusions
Alloimmunization continues to challenge transfusion management in adults with SCD. Broader implementation of extended antigen matching and genotype-informed transfusion strategies may help mitigate this risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine, King Faisal University, Al Ahsa 31982, Saudi Arabia.
- College of Medicine, King Faisal University, Al Ahsa 31982, Saudi Arabia.
- Department of Laboratory and Blood Bank, Prince Saud bin Jalawi Hospital, Al Ahsa 36377, Saudi Arabia.
- Department of Family and Community Medicine, College of Medicine, King Faisal University, Al Ahsa 31982, Saudi Arabia.
ORCID-Profile: Mortadah Alsalman, Jawad S Alnajjar, Sarra Riyadh Alhassan, Abdullah Almaqhawi
Förderung
- The Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research at King Faisal University in Saudi Arabia gave this study mon…
- Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research at King Faisal University
Zitieren
APA
Alsalman, M., Alnajjar, J. S., Alhassan, S. R., Almarzoug, H. A., Alobaid, Q. A., Alhassan, R. R., Alshams, M. M., Almoqren, B. A., Al Besher, N. B., & Almaqhawi, A. (2026). Global Prevalence of Alloimmunization in Adults with Sickle Cell Disease Receiving Red Blood Cell Transfusions: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 15(10), 3828. https://doi.org/10.3390/jcm15103828
Vancouver
Alsalman M, Alnajjar JS, Alhassan SR, Almarzoug HA, Alobaid QA, Alhassan RR, et al. Global Prevalence of Alloimmunization in Adults with Sickle Cell Disease Receiving Red Blood Cell Transfusions: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2026;15(10):3828. doi:10.3390/jcm15103828
BibTeX
@article{Alsalman2026,
author = {Alsalman, Mortadah and Alnajjar, Jawad S and Alhassan, Sarra Riyadh and Almarzoug, Hussain A and Alobaid, Qusai A and Alhassan, Reham Riyadh and Alshams, Maryam Mohammed and Almoqren, Bdoor Abdulaziz and Al Besher, Nabeel Baqer and Almaqhawi, Abdullah},
title = {Global Prevalence of Alloimmunization in Adults with Sickle Cell Disease Receiving Red Blood Cell Transfusions: A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {10},
pages = {3828},
doi = {10.3390/jcm15103828}
}
EUVIMED